Second Generation Cell and Gene-Based Therapies Biological Advances, Clinical Outcomes and Strategies for Capitalisation
Afbeeldingen
Sla de afbeeldingen overArtikel vergelijken
Auteur:
Alain Vertes
- Engels
- Hardcover
- 9780128120347
- 10 februari 2020
- 846 pagina's
Samenvatting
Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the market to bridge basic science, clinical therapy, technology development, and business in the field of cellular therapy/cytotherapy. After more than two decades of painstaking fundamental research, the concept of therapeutic cells (stem cells, genes, etc.), beyond the concept of vaccines, is reaching clinical trial, with mounting confidence in the safety and efficacy of these products. Nonetheless, numerous incremental technical advances remain to be achieved. Thus, this volume highlights the possible R&D paths, which will ultimately facilitate clinical delivery of cutting edge curative products.
The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals.
The next waves of innovation are reviewed in depth for hematopoietic stem cells, mesenchymal stem cells, tissue engineering, CAR-T cells, and cells of the immune system, as well as for enabling technologies such as gene and genome editing. Additionally, deep dives in product fundamentals, history of science, pathobiology of diseases, scientific and technological bases, and financing and technology adoption constraints are taken to unravel what will shape the cytotherapy industry to the horizon 2025 and beyond. The outcome is not simply a scientific book, but a global perspective on the nascent field combining science, business, and strategic fundamentals.
- Helps readers learn about the most current trends in cell-based therapy, their overall effectiveness from a clinical prospective, and how the industry is moving therapies forward for capitalization
- "Perspectives" section at the end of each chapter summarizes key learnings, hypotheses, and objectives highlighted and combines scientific and business insights
- Edited and authored by scientists representing both basic and clinical research and industry, presenting a complete story of the current state and future promise of cellular therapies
Productspecificaties
Wij vonden geen specificaties voor jouw zoekopdracht '{SEARCH}'.
Inhoud
- Taal
- en
- Bindwijze
- Hardcover
- Oorspronkelijke releasedatum
- 10 februari 2020
- Aantal pagina's
- 846
- Illustraties
- Nee
Betrokkenen
- Hoofdauteur
- Alain Vertes
- Hoofdredacteur
- Alain Vertes
- Tweede Redacteur
- Nathan J. Dowden
- Co Redacteur
- Nasib Qureshi
- Hoofduitgeverij
- Academic Press Inc
Overige kenmerken
- Extra groot lettertype
- Nee
- Product breedte
- 191 mm
- Product lengte
- 235 mm
- Studieboek
- Ja
- Verpakking breedte
- 152 mm
- Verpakking hoogte
- 229 mm
- Verpakking lengte
- 235 mm
- Verpakkingsgewicht
- 1860 g
EAN
- EAN
- 9780128120347
Je vindt dit artikel in
- Categorieën
- Boek, ebook of luisterboek?
- Boek
- Beschikbaarheid
- Leverbaar
- Taal
- Engels
- Studieboek of algemeen
- Algemene boeken
Kies gewenste uitvoering
Bindwijze
: Hardcover
Prijsinformatie en bestellen
De prijs van dit product is 150 euro en 99 cent.
3 - 4 weken
Verkoop door bol
- Prijs inclusief verzendkosten, verstuurd door bol
- Ophalen bij een bol afhaalpunt mogelijk
- 30 dagen bedenktijd en gratis retourneren
- Dag en nacht klantenservice
Rapporteer dit artikel
Je wilt melding doen van illegale inhoud over dit artikel:
- Ik wil melding doen als klant
- Ik wil melding doen als autoriteit of trusted flagger
- Ik wil melding doen als partner
- Ik wil melding doen als merkhouder
Geen klant, autoriteit, trusted flagger, merkhouder of partner? Gebruik dan onderstaande link om melding te doen.